Abbott Laboratories Basic Shares Outstanding 2010-2024 | ABT

Abbott Laboratories annual/quarterly basic shares outstanding history and growth rate from 2010 to 2024. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
  • Abbott Laboratories basic shares outstanding for the quarter ending December 31, 2024 were $M, a 100% decline year-over-year.
  • Abbott Laboratories basic shares outstanding for the twelve months ending December 31, 2024 were $5.223B, a 24.97% decline year-over-year.
  • Abbott Laboratories annual basic shares outstanding for 2024 were $0B, a 100% decline from 2023.
  • Abbott Laboratories annual basic shares outstanding for 2023 were $1.74B, a 0.74% decline from 2022.
  • Abbott Laboratories annual basic shares outstanding for 2022 were $1.753B, a 1.24% decline from 2021.
Abbott Laboratories Annual Basic Shares Outstanding
(Millions of US $)
2024 $
2023 $1,740
2022 $1,753
2021 $1,775
2020 $1,773
2019 $1,768
2018 $1,758
2017 $1,740
2016 $1,477
2015 $1,496
2014 $1,516
2013 $1,558
2012 $1,575
2011 $1,557
2010 $1,546
2009 $1,547
Abbott Laboratories Quarterly Basic Shares Outstanding
(Millions of US $)
2024-12-31
2024-09-30 $1,739
2024-06-30 $1,743
2024-03-31 $1,740
2023-12-31 $1,740
2023-09-30 $1,739
2023-06-30 $1,740
2023-03-31 $1,742
2022-12-31 $1,753
2022-09-30 $1,753
2022-06-30 $1,754
2022-03-31 $1,762
2021-12-31 $1,775
2021-09-30 $1,775
2021-06-30 $1,779
2021-03-31 $1,777
2020-12-31 $1,773
2020-09-30 $1,774
2020-06-30 $1,773
2020-03-31 $1,769
2019-12-31 $1,768
2019-09-30 $1,772
2019-06-30 $1,769
2019-03-31 $1,763
2018-12-31 $1,758
2018-09-30 $1,760
2018-06-30 $1,758
2018-03-31 $1,753
2017-12-31 $1,740
2017-09-30 $1,744
2017-06-30 $1,741
2017-03-31 $1,727
2016-12-31 $1,477
2016-09-30 $1,476
2016-06-30 $1,475
2016-03-31 $1,477
2015-12-31 $1,496
2015-09-30 $1,495
2015-06-30 $1,494
2015-03-31 $1,505
2014-12-31 $1,516
2014-09-30 $1,509
2014-06-30 $1,507
2014-03-31 $1,533
2013-12-31 $1,558
2013-09-30 $1,552
2013-06-30 $1,561
2013-03-31 $1,569
2012-12-31 $1,575
2012-09-30 $1,577
2012-06-30 $1,572
2012-03-31 $1,574
2011-12-31 $1,557
2011-09-30 $1,559
2011-06-30 $1,557
2011-03-31 $1,552
2010-12-31 $1,546
2010-09-30 $1,545
2010-06-30 $1,544
2010-03-31 $1,548
2009-12-31 $1,547
2009-09-30 $1,546
2009-06-30 $1,546
2009-03-31 $1,546
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $229.174B $41.950B
Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson.
Stock Name Country Market Cap PE Ratio
Boston Scientific (BSX) United States $155.945B 42.10
Stryker (SYK) United States $148.251B 31.87
EssilorLuxottica (ESLOY) France $140.098B 0.00
Medtronic (MDT) Ireland $111.559B 16.29
Lonza Group Ag (LZAGY) Switzerland $46.232B 0.00
Haleon (HLN) United Kingdom $45.180B 29.35
GE HealthCare Technologies (GEHC) United States $42.309B 20.61
Agilent Technologies (A) United States $39.127B 25.93
ResMed (RMD) United States $34.442B 26.53
Terumo (TRUMY) Japan $26.591B 37.81
Koninklijke Philips (PHG) Netherlands $23.545B 16.81
Zimmer Biomet Holdings (ZBH) United States $20.572B 12.92
Insulet (PODD) United States $19.899B 79.24
Baxter (BAX) United States $15.736B 10.24
Sunny Optical Technology (SNPTF) China $11.331B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $11.201B 0.00
BellRing Brands (BRBR) United States $9.927B 37.20
Demant (WILYY) Denmark $7.946B 0.00
Bio-Rad Laboratories (BIO) United States $7.944B 27.52
Lantheus Holdings (LNTH) United States $5.659B 13.15
Prestige Consumer Healthcare (PBH) United States $4.205B 20.07
ICU Medical (ICUI) United States $4.019B 38.26
Envista Holdings (NVST) United States $3.747B 29.81
Perrigo (PRGO) Ireland $3.383B 9.96
Haemonetics (HAE) United States $3.198B 15.05
Shandong Weigao Medical Polymer (SHWGF) China $2.989B 0.00
GN Store Nord (GNNDY) Denmark $2.913B 19.63
QuidelOrtho (QDEL) United States $2.817B 23.67
LeMaitre Vascular (LMAT) United States $2.319B 56.37
Neogen (NEOG) United States $2.232B 25.73
AtriCure (ATRC) United States $1.907B 0.00
Green Thumb Industries (GTBIF) United States $1.484B 25.89
InMode (INMD) Israel $1.349B 11.28
BioLife Solutions (BLFS) United States $1.296B 0.00
AdaptHealth (AHCO) United States $1.211B 8.65
Maravai LifeSciences Holdings (MRVI) United States $1.030B 0.00
Phibro Animal Health (PAHC) United States $0.979B 15.01
Evolus (EOLS) United States $0.942B 0.00
Curaleaf Holdings (CURLF) Canada $0.918B 0.00
CeriBell (CBLL) United States $0.794B 0.00
Capricor Therapeutics (CAPR) United States $0.686B 0.00
Valneva SE (VALN) France $0.613B 0.00
Omeros (OMER) United States $0.536B 0.00
VAREX IMAGING (VREX) United States $0.529B 22.95
Owens & Minor (OMI) United States $0.527B 4.12
Surmodics (SRDX) United States $0.491B 0.00
SNDL (SNDL) Canada $0.465B 0.00
Cresco Labs (CRLBF) United States $0.438B 0.00
ZimVie (ZIMV) United States $0.368B 31.00
SEMPERIT AG HLD (SEIGY) Austria $0.349B 0.00
Verano Holdings (VRNOF) United States $0.341B 0.00
Cerus (CERS) United States $0.336B 0.00
Aurora Cannabis (ACB) Canada $0.318B 57.90
Viemed Healthcare (VMD) United States $0.315B 30.00
Sanara MedTech (SMTI) United States $0.309B 0.00
Quanterix (QTRX) United States $0.301B 0.00
OraSure Technologies (OSUR) United States $0.294B 19.70
Biote (BTMD) United States $0.266B 5.83
Canopy Growth (CGC) Canada $0.260B 0.00
Zynex (ZYXI) United States $0.239B 50.13
Sanuwave Health (SNWV) United States $0.236B 3.31
Brainsway (BWAY) Israel $0.213B 113.20
High Tide (HITI) Canada $0.210B 0.00
Utah Medical Products (UTMD) United States $0.206B 15.40
MacroGenics (MGNX) United States $0.183B 0.00
TriSalus Life Sciences (TLSI) United States $0.174B 0.00
Organigram Holdings (OGI) Canada $0.167B 0.00
TerrAscend (TSNDF) Canada $0.147B 0.00
FitLife Brands (FTLF) United States $0.141B 17.65
Jin Medical (ZJYL) China $0.122B 0.00
Quipt Home Medical (QIPT) United States $0.115B 0.00
Fonar (FONR) United States $0.095B 13.08
Oramed Pharmaceuticals (ORMP) United States $0.094B 0.00
Veru (VERU) United States $0.088B 0.00
InterCure (INCR) Israel $0.073B 0.00
Exagen (XGN) United States $0.068B 0.00
Jushi Holdings (JUSHF) United States $0.068B 0.00
Cytosorbents (CTSO) United States $0.067B 0.00
Rockwell Medical (RMTI) United States $0.060B 30.83
Apyx Medical (APYX) United States $0.056B 0.00
MariMed (MRMD) United States $0.052B 0.00
Hongchang (HCIL) China $0.051B 0.00
United-Guardian (UG) United States $0.049B 14.17
ImmuCell (ICCC) United States $0.046B 0.00
INLIF (INLF) $0.046B 0.00
Modular Medical (MODD) United States $0.045B 0.00
Safety Shot (SHOT) United States $0.031B 0.00
Nephros (NEPH) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Innovative Eyewear (LUCY) United States $0.011B 0.00
Allurion Technologies (ALUR) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.009B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Agape ATP (ATPC) $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
Sharps Technology (STSS) United States $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00